Goldman Sachs Downgrades Ginkgo Bioworks Holdings Inc (DNA) to Sell, 'Softening end market demand'
Tweet Send to a Friend
(Updated - June 2, 2023 4:28 AM EDT)
Goldman Sachs analyst Matthew Sykes downgraded Ginkgo Bioworks Holdings Inc (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes downgraded Ginkgo Bioworks Holdings Inc (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
